On November 18, 2022, Twist Bioscience presented the quarterly figures for the most recent quarter – closing date September 30, 2022 – at the financial conference.
EPS came in at -$0.910. A year earlier it had returned -$0.840 per share.
On the revenue side, Twist Bioscience posted $57.3 million for the past quarter. This corresponds to an increase in sales of 51.01 percent compared to the previous year’s result. At that time Twist Bioscience had a turnover of 38.0 million USD.
Loss per share for the full year was reported at $4,040. In the previous year -3,150 USD had been generated.
On the revenue side, an increase of 53.84 percent was generated compared to the revenue generated in the previous year in the amount of USD 132.33 million. Accordingly, the most recent annual revenue was reported at $203.57 million.
For the fiscal year, analysts had expected a loss per share of $4.394 and revenue of $202.91 million.
Editorial office finanzen.net
Leverage must be between 2 and 20
No data